Azilsartan in Patients With Mild to Moderate Hypertension Using Clinic and Ambulatory Blood Pressure Measurements-Reference-Cited by-同舟云学术

Azilsartan in Patients With Mild to Moderate Hypertension Using Clinic and Ambulatory Blood Pressure Measurements

Published:2016-07-15 Issue:1 Volume:19 Page:82-89
ISSN:1524-6175
Container-title:The Journal of Clinical Hypertension
language:en
Short-container-title:J Clin Hypertens

Author:

Perez Alfonso¹,Cao Charlie¹

Affiliation:

1. Takeda Development Center Americas, Inc.; Deerfield IL

Funder

Takeda Pharmaceuticals U.S.A.

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jch.12873/fullpdf

Reference18 articles.

1. Differential pharmacology and benefit/risk of azilsartan compared to other sartans;Kurtz;Vasc Health Risk Manag,2012

2. A systematic comparison of the properties of clinically used angiotensin II type 1 receptor antagonists;Michel;Pharmacol Rev,2013

3. U.S. Food and Drug Administration, Center for Drug Evaluation and Research Azilsartan medoxomil (Edarbi) NDA 200-796 Clinical Pharmacology and Biopharmaceutics Review http://www.accessdata.fda.gov/drugsatfda_docs/nda/2011/200

4. Edarbi (azilsartan medoxomil) tablets. U.S. prescribing information http://www.accessdata.fda.gov/drugsatfda_docs/label/2014/2

5. Edarbi (azilsartan medoxomil) tablets. Summary of product characteristics http://www.ema.europa.eu/docs/en_GB/document_library/EPAR_

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of olmesartan medoxomil‐amlodipine besylate tablet in Chinese patients with essential hypertension: A prospective, single‐arm, multi‐center, real‐world study;The Journal of Clinical Hypertension;2023-09-04

2. Safety and efficacy of azilsartan in paediatric patients with hypertension: a phase 3, single-arm, open-label, prospective study;Clinical and Experimental Nephrology;2021-11-27

3. Single-pill Combination Therapy of Azilsartan Medoxomil/Chlorthalidone for Treatment of Hypertension: A Systematic Review;Clinical Therapeutics;2020-07

4. Azilsartan piperazine salt solvate and monohydrate: preparation, crystal structure, enhanced solubility and oral bioavailability;New Journal of Chemistry;2020

5. Preparation and in vitro/in vivo evaluation of azilsartan osmotic pump tablets based on the preformulation investigation;Drug Development and Industrial Pharmacy;2019-03-25